Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center

被引:46
|
作者
Zandberg, Dan P. [1 ,2 ]
Liu, Sandy [3 ]
Goloubeva, Olga [2 ]
Ord, Robert [2 ,4 ]
Strome, Scott E. [5 ]
Suntharalingam, Mohan [6 ]
Taylor, Rodney [5 ]
Morales, Robert E. [7 ]
Wolf, Jeffrey S. [5 ]
Zimrin, Ann [1 ,2 ]
Lubek, Joshua E. [2 ,4 ]
Schumaker, Lisa M. [2 ]
Cullen, Kevin J. [1 ,2 ]
机构
[1] Univ Maryland, Sch Med, Dept Med, Div Med Oncol, Baltimore, MD 21201 USA
[2] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Oral & Maxillofacial Surg, Baltimore, MD 21201 USA
[5] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA
[6] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA
[7] Univ Maryland, Sch Med, Dept Radiol, Baltimore, MD 21201 USA
关键词
race; head and neck squamous cell carcinoma (HNSCC); oropharyngeal; survival; disparity; HUMAN-PAPILLOMAVIRUS; TREATMENT PATTERNS; AFRICAN-AMERICANS; PHARYNGEAL CANCER; LARYNGEAL-CANCER; ORAL-CANCER; SURVIVAL; STAGE; RACE; STATISTICS;
D O I
10.1002/hed.23933
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Racial outcome disparities have been observed in head and neck squamous cell carcinoma (HNSCC) with diminished survival for black patients compared with white patients. Methods. We retrospectively analyzed 1318 patients with primary HNSCC treated at the University of Maryland Greenebaum Cancer Center (UMGCC) from 2000 to 2010. Results. Of all the patients, 65.9% were white, 30.7% were black, and 3.3% were of other races. Black patients were less likely to present with oral cavity cancer, and more likely to present with laryngeal or hypopharyngeal cancers. White patients were more likely to have early stage disease, especially in the oral cavity. Black race was independently associated with worse overall survival (OS) in the entire cohort. Black patients had a significantly worse OS among oral cavity and oropharyngeal cancers, with the largest disparity in oropharyngeal cancer. However, in multivariate analysis, race was only still significant in oropharyngeal cancer. Conclusion. We observed differences by race in distribution of disease site, stage, and OS. Survival disparity in the entire cohort was driven mostly by differences among oropharyngeal cancer. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:564 / 572
页数:9
相关论文
共 50 条
  • [31] Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer -: An 8-year single-institution experience
    Lavertu, P
    Adelstein, DJ
    Saxton, JP
    Secic, M
    Eliachar, I
    Strome, M
    Larto, MA
    Wood, BG
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1999, 125 (02) : 142 - 148
  • [32] Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year results
    Marius Breheret
    Dorota Lubgan
    Marlen Haderlein
    Markus Hecht
    Maximilian Traxdorf
    Daniela Schmidt
    Sarina Müller
    Christian Kitzsteiner
    Torsten Kuwert
    Heinrich Iro
    Rainer Fietkau
    Sabine Semrau
    European Archives of Oto-Rhino-Laryngology, 2020, 277 : 245 - 254
  • [33] CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma
    Fukusumi, T.
    Ishii, H.
    Konno, M.
    Yasui, T.
    Nakahara, S.
    Takenaka, Y.
    Yamamoto, Y.
    Nishikawa, S.
    Kano, Y.
    Ogawa, H.
    Hasegawa, S.
    Hamabe, A.
    Haraguchi, N.
    Doki, Y.
    Mori, M.
    Inohara, H.
    BRITISH JOURNAL OF CANCER, 2014, 111 (03) : 506 - 514
  • [34] CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma
    T Fukusumi
    H Ishii
    M Konno
    T Yasui
    S Nakahara
    Y Takenaka
    Y Yamamoto
    S Nishikawa
    Y Kano
    H Ogawa
    S Hasegawa
    A Hamabe
    N Haraguchi
    Y Doki
    M Mori
    H Inohara
    British Journal of Cancer, 2014, 111 : 506 - 514
  • [35] Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year results
    Breheret, Marius
    Lubgan, Dorota
    Haderlein, Marlen
    Hecht, Markus
    Traxdorf, Maximilian
    Schmidt, Daniela
    Mueller, Sarina
    Kitzsteiner, Christian
    Kuwert, Torsten
    Iro, Heinrich
    Fietkau, Rainer
    Semrau, Sabine
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (01) : 245 - 254
  • [36] The effect of locality of residence (LOR) and socioeconomic status (SES) on mortality in patients with squamous cell carcinoma of the head and neck (HNSCC): 20-year experience at the UPMC Hillman Cancer Center.
    Taylor, Janielle
    Shuai, Yongli
    Robertson, Linda
    Normolle, Daniel Paul
    Ferris, Robert L.
    Bear, Todd
    Nilsen, Marci Lee
    Johnson, Jonas T.
    Kubik, Mark
    Sridharan, Shaum
    Duvvuri, Umamaheswar
    Wang, Eric
    Skinner, Heath Devin
    Clump, David Anthony
    Ohr, James
    Snyderman, Carl
    Chiosea, Simion, I
    Gish-Johnson, Rachelle
    Kim, Seungwon
    Zandberg, Dan Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Efficacy and tolerability of nimotuzumab in combination with chemotherapy in recurrent and metastatic squamous cell carcinoma of head and neck at a cancer center in Northern India
    Yadav, Abhishek
    Goyal, Pankaj
    Agrawal, Chaturbhuj R.
    Bothra, Sneha J.
    Jain, Parveen
    Choudhury, Kumardeep Dutta
    Gupta, Sunil Kumar
    Sharma, Manish
    Bajaj, Rajat
    Upadhyay, Amitabh
    Dash, Prashanta
    Doval, Dinesh C.
    INDIAN JOURNAL OF CANCER, 2020, 57 (01) : 76 - 83
  • [38] Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck - An Illinois Cancer Center Study
    Rosen, F
    Vokes, EE
    Lad, T
    Kies, M
    Wade, J
    Kilton, LJ
    Blough, R
    French, S
    Mullane, M
    Benson, AB
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (03) : 249 - 252
  • [39] Patterns of Care and Outcome for N3 Head and Neck Squamous Cell Carcinoma: Review of the National Cancer Data Base
    Ko, H. C.
    Brower, J. V.
    Baschnagel, A. M.
    Hullett, C. R.
    Wieland, A.
    Harari, P. M.
    Witek, M. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E336 - E336
  • [40] Risk factors affect the survival outcome of hard palatal and maxillary alveolus squamous cell carcinoma: 10-year review in a tertiary referral center
    Wang, Tang Chuan
    Hua, Chun Hun
    Lin, Ching Chia
    Tsou, Yung-An
    Tseng, Hsien Chang
    Tsai, Ming Hsui
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2010, 110 (01): : 11 - 17